← SynDRA

MAVORIXAFOR

SynDRA canonical compound SYN0018464 — structure-anchored drug synonym record

All known targets

• CXCR4
• CCR5

Mechanisms of action (all sources)

• CXCR4 ANTAGONIST
• C-X-C chemokine receptor type 4 antagonist
• CC chemokine receptor antagonist

ATC classes

• L03A · IMMUNOSTIMULANTS

Cross-references

• PubChem CID: 11256587
• ChEMBL: CHEMBL518924
• DrugBank: DB05501
• ChEBI: 138865
• KEGG: C20266
• RxNorm: 2684021
• PDB: A1D8L
• Wikipedia: Mavorixafor
• TTD: D0O2XQ
• LINCS BRD: BRD-K42948882

Synonyms

• AMD-070
• Cxcr4 inhibitor x4p-001
• X4p001
• Xolremdi
• AMD-11070
• AMD070
• AMD11070
• X 4P-001
• X4P-001
• AMD 070
• S14-0353
• N-(1H-benzoimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
• N'-(1H-Benzo[d]imidazol-2-ylmethyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine Trihydrobromide Dihydrate
• XOLREMDI
• X4P 001
• AMD 11070
• 0G9LGB5O2W
• mavorixaforum
• RefChem:155995
• Mavorixafor [USAN]
• UNII-0G9LGB5O2W
• MFCD11977316
• Mavorixafor (USAN)
• C21H27N5
• Xolremdi (TN)
• Mavorixafor free base
• compound 2 [PMID: 20297846]
• AMD-070 (AMD11070)
• AMD-070; Mavorixafor
• MAVORIXAFOR [INN]
• A1D8L
• MAVORIXAFOR [WHO-DD]
• GTPL8580
• orb1296155
• SCHEMBL2511950
• SCHEMBL29379072
• SCHEMBL29701264
• CHEBI:138865
• GLXC-04447